Scarica l'app Stockscreener
16.50
0.00%
0.00
Dopo l'orario di chiusura:
16.60
0.10
+0.61%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
An insulin-delivery company will hold a results call Nov. 5 at 4:30 p.m. ET. - Stock Titan
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks - Yahoo Finance
TNDM Maintained by Citigroup -- Price Target Lowered to $20 - GuruFocus
Operating cash flow per share of Tandem Diabetes Care, Inc. – HAN:TD5A - TradingView
Tandem Diabetes Care, Inc. (0M0F.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tandem Diabetes (TNDM) Expands Mobi Insulin Delivery System to 1 - GuruFocus
Tandem Diabetes Expands Insulin Delivery System to 12 New Countries - marketscreener.com
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets - Nasdaq
A Look at Tandem Diabetes Care Inc (TNDM) After 3.3% Gain -- GF Value $24.10 vs Price $15.72 - GuruFocus
TNDM Maintained by Truist Securities -- Price Target Lowered to $28 - GuruFocus
Tandem Insulin Pump Lawsuit Alleges Delivery Failure Led to 15-Year-Old Girl’s Death - AboutLawsuits.com
Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating - marketscreener.com
The Technical Signals Behind (TNDM) That Institutions Follow - Stock Traders Daily
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance
A Look at Tandem Diabetes Care Inc (TNDM) After 6.4% Decline -- GF Value $24.09 vs Price $16.38 - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 62.88% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Is Tandem Diabetes Care (TNDM) Undervalued As Investors Weigh Its 34% One Year Return? - Yahoo Finance
Officer at Tandem Diabetes Care (NASDAQ: TNDM) plans 360-share stock sale - Stock Titan
Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance Singapore
A Look at Tandem Diabetes Care Inc (TNDM) After 7.7% Gain -- GF Value $24.08 vs Price $17.54 - GuruFocus
(TNDM) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tandem Diabetes Care: Stop Paying For Tomorrow's ProfitsStrong Sell (NASDAQ:TNDM) - Seeking Alpha
Is Tandem Diabetes Care Inc (TNDM) a Bargain After 4.2% Drop? GF Value Says Undervalued - GuruFocus
Zacks Investment Research - גלובס
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now - Yahoo Finance
(TNDM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
A Look at Tandem Diabetes Care Inc (TNDM) After 3.4% Decline -- GF Value $24.05 vs Price $20.56 - GuruFocus
Tandem Diabetes Care stock gains after recent rally in diabetes tech - ad-hoc-news.de
TANDEM DIABETES CARE INC (TNDM) Stock Chart - ChartMill
Tandem Diabetes Care (TNDM) Edges Higher to $21.49, Holding Above Key SupportGrowth ETF - vinanet.vn
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking - Sahm
Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat? - TradingView
TNDM Initiated Coverage On by William Blair -- Rating Set to Out - gurufocus.com
Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics - Benzinga
William Blair initiates Tandem Diabetes stock with outperform rating By Investing.com - Investing.com Nigeria
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript - AOL.com
How Tandem’s Q2 Loss and Pharmacy Pivot Will Impact Tandem Diabetes Care (TNDM) Investors - simplywall.st
Tandem (TNDM) Earnings Brief: Profit Per Share Clears Its Benchmark in the Current Update; Price Action: Shares Finish 6.63% Up at the CloseEarnings Season Preview - Vinanet
Tandem Diabetes Care CFO Leigh Vosseller Reports RSU Vesting Transactions on August 15, 2026 - Kalkine Media
Tandem Diabetes Care CEO John F. Sheridan Reports August 2026 RSU Vesting and Tax Withholding Details - Kalkine Media
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Sheridan John F - Moomoo
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Morrison Susan - Moomoo
Tandem Diabetes (TNDM) CFO vests RSUs as shares withheld for tax - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) exec nets 475 shares after RSU vesting - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CEO vests 15,916 RSUs as shares withheld for tax - Stock Titan
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Kyrillos Jean-Claude - Moomoo
Tandem Diabetes (NASDAQ: TNDM) CSO vests 3,014 RSUs, 1,618 withheld - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CLO RSUs vest, with shares withheld for taxes - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CTO withholds 1,277 shares to cover RSU taxes - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) holder to sell 131 RSU shares - Stock Titan
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):